What are the current treatment guidelines for scalp psoriasis?

Treatment Guidelines for Scalp Psoriasis

For scalp psoriasis, initiate treatment with topical corticosteroids (class 1-7) for up to 4 weeks as first-line therapy, with combination calcipotriene plus betamethasone dipropionate gel being the most effective option for 4-12 weeks. 1

First-Line Treatment Approach

Topical Corticosteroids

• Any potency class (1-7) can be used for scalp psoriasis, unlike body psoriasis where lower potencies are restricted to sensitive areas 1
• Treatment duration: minimum of up to 4 weeks for both initial and maintenance therapy (Level I evidence, Strength A recommendation) 1
• Efficacy rates for ultrahigh-potency (class 1) agents range from 58-92% 1
• Vehicle selection is critical for scalp application—foams and gels improve patient compliance over ointments

Combination Therapy (Preferred)

Calcipotriene plus betamethasone dipropionate gel is recommended as the most effective scalp treatment for 4-12 weeks (Strength A recommendation) 1

• In 52-week studies, 69-74% of patients achieved clear or almost clear status versus 27% with vehicle (P < .001) 1
• Superior efficacy to either agent alone 1
• No serious adverse events including striae or HPA axis suppression observed over 52 weeks 1

Alternative First-Line Options

Vitamin D Analogues

• Calcipotriene foam as monotherapy is effective for 4-12 weeks (Strength A recommendation) 1
• Can be used long-term (up to 52 weeks) 1
• Critical caveat: Avoid simultaneous use with salicylic acid—the acidic pH inactivates calcipotriene 1

Maintenance Strategies

Steroid-Sparing Regimens

Two evidence-based approaches to reduce corticosteroid exposure:

1. Weekend-weekday rotation: High-potency topical corticosteroids twice daily on weekends + vitamin D analogues twice daily on weekdays (Strength B recommendation) 1

2. Morning-evening split: High-potency corticosteroids in morning + vitamin D analogues in evening (Strength B recommendation) 1

Extended Use Considerations

• Topical corticosteroids can be used beyond 12 weeks under careful physician supervision (Strength C recommendation) 1
• Gradual tapering after clinical improvement is recommended to avoid rebound, though exact protocols are not well-established 1

Refractory Disease Management

Intralesional Corticosteroids

• Triamcinolone acetonide up to 20 mg/mL every 3-4 weeks for localized non-responding scalp lesions 1

Systemic Therapy

For severe or widespread scalp psoriasis not responding to topicals:

• Biologics: Anti-IL-17 and anti-IL-23 agents show significant efficacy 2
• Tildrakizumab 100 mg demonstrated 49.4% IGA response at week 16 versus 7.3% with placebo (P < .00001) in scalp-specific trials 3
• Consider systemic agents when scalp involvement is part of moderate-to-severe body psoriasis 4, 2

Critical Pitfalls to Avoid

1. Do not apply vitamin D analogues before phototherapy—UVA inactivates calcipotriene and thick layers block UVB 1

2. Avoid abrupt discontinuation of potent corticosteroids—taper gradually to prevent rebound, though frequency is variable 1

3. Do not use salicylic acid with calcipotriene—incompatible due to pH inactivation 1

4. Monitor for local adverse effects with prolonged corticosteroid use: skin atrophy, telangiectasia, folliculitis (though scalp is less prone than facial/intertriginous areas) 1

Treatment Selection Algorithm

Mild-moderate scalp psoriasis → Calcipotriene/betamethasone combination gel 4-12 weeks

If inadequate response → Switch to ultrahigh-potency corticosteroid (class 1) monotherapy

For maintenance → Transition to weekend corticosteroid/weekday vitamin D analogue regimen

Localized resistant plaques → Add intralesional triamcinolone acetonide

Severe/widespread disease → Escalate to systemic therapy (biologics preferred for scalp-predominant disease)